-
Outpatient care centers have historically attracted little attention from the Occupational Safety and Health Administration, although needle market data show they have lagged in sharps safety and been a recurrent source of hepatitis outbreaks among patients.
-
OK, maybe duct tape really can fix everything. A simple red roll of this prime tool in the kit of every weekend repairman led to some rather startling results for innovative infection preventionists.
-
The Centers for Medicare and Medicaid Services (CMS) the single largest payer for health care in the United States is creating a hospital inspection program focused specifically on infection control, Hospital Infection Control & Prevention has learned.
-
-
-
The Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) study showed that in patients with stable coronary artery disease (CAD) put on optimal medical therapy (OMT) that randomization to a percutaneous coronary intervention did not improve survival or prevent myocardial infarction.
-
The authors conclude that even short-term treatment with most NSAIDs was associated with increased risk of death and recurrent MI in patients with prior MI. Neither short- nor long-term treatment with NSAIDs is advised in this population, and any NSAID use should be limited from a cardiovascular safety point of view.
-
Two new drugs for treatment of hepatitis C; NSAIDs and myocardial infarction risk; AIM-HIGH clinical trial stopped; and FDA actions.
-
In this paper, Haines and his coauthors propose a scoring system to predict risks associated with implantable cardioverterdefibrillator (ICD) implant procedures.
-
RE-LY randomized 18,113 patients to one of its three arms. In the entire study group, dabigatran 110 mg twice per day compared with warfarin was associated with lower risks of major bleeding (2.87% vs 3.57 %), intracranial bleeding (0.23% vs 0.76%), and life-threatening bleeding (1.24% vs 1.85%).